Data coverage, completeness and provenance for CERYVYN THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T01:45:29. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0110 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/CYV/prices · Price parameters and adjustment semantics
Ceryvyn Therapeutics Limited, a biopharmaceutical company, develops biologic therapy for the rare disease lymphangioleiomyomatosis in Australia. The company offers CYV-101, which is in pre-clinical trial stage, an inhaled therapy intended for delivery directly to the lung. It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Hawthorn East, Australia.
Website: https://ceryvyn.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/CYV/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 22 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 25 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 27 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 29 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 11 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/CYV
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/CYV/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/CYV/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/CYV/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/CYV/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/CYV
Free tier — instant API key. Built for AI agents.